31 – 40 of 200
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
The saga of MAX IV, the first multi-bend achromat synchrotron light source
2018) In Nuclear Instruments and Methods in Physics Research, Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 907. p.97-104(
- Contribution to journal › Scientific review
-
Mark
Working to improve the management of sarcoma patients across Europe : A policy checklist
(
- Contribution to journal › Article
-
Mark
Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment
(
- Contribution to journal › Article
-
Mark
Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors—A Scandinavian Sarcoma Group study (SSG XX)
(
- Contribution to journal › Article
-
Mark
PETRA IV : the ultralow-emittance source project at DESY
(
- Contribution to journal › Article
-
Mark
Occupational exposure to organic solvents and risk of male breast cancer : A European multicenter case-control study
(
- Contribution to journal › Article
-
Mark
EURO-B.O.S.S. : A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma
(
- Contribution to journal › Article
- 2017
-
Mark
Cohort Profile : The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA)
(
- Contribution to journal › Article
-
Mark
SLUG transcription factor : A pro-survival and prognostic factor in gastrointestinal stromal tumour
(
- Contribution to journal › Article
-
Mark
Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib : An exploratory analysis of a randomized clinical trial
(
- Contribution to journal › Article